Kilitch Drugs to Sell Ethiopian Subsidiary for USD 14 Million
Kilitch Drugs has planned to sell its Ethiopian subsidiary for USD 14 million, reallocating capital to Indian growth, debt repayment and pharma expansion.
Kilitch Drugs | 24/10/2026 | By News Bureau
Where Will Pharma Investments Head Next?
As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.
Kilitch Drugs | 03/12/2025 | By Akanki | 646
Bhavin Mukund Mehta Joins Pharmexcil as its Vice-Chairman
Mehta, an industry veteran with over 25 years of experience, has been instrumental in expanding Kilitch Drugs’ presence in international markets while strengthening its foothold in India.
Kilitch Drugs | 05/02/2025 | By Aishwarya | 730
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy